| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/04/2013 | WO2013055104A3 Composition for preventing and treating overactive bladder syndrome |
| 07/04/2013 | US20130171206 Method for treating or preventing renal or liver disease |
| 07/03/2013 | EP2610253A1 Nifuratel sulfoxide for use in the treatment of bacterial infections. |
| 07/03/2013 | EP2609915A1 Dialysis and substitution fluid |
| 07/03/2013 | EP2609218A1 Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays |
| 07/03/2013 | EP2608793A1 Use of a receptor-type kinase modulator for treating polycystic kidney disease |
| 07/03/2013 | CN103183726A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 07/03/2013 | CN103183660A Chromane derivative used as TRPV3 (transient receptor potential vanilloid 3) conditioning agent |
| 07/03/2013 | CN103183659A Chromane derivative used as TRPV3 (transient receptor potential vanillin 3) regulator |
| 07/03/2013 | CN103183630A Substituted 4-aminocyclohexane derivatives |
| 07/03/2013 | CN103183606A 4,4'-dibasic benzophenone compound and preparation method thereof |
| 07/03/2013 | CN103182040A Traditional Chinese medicine composition for treating polycystic kidney disease, and preparation method thereof |
| 07/03/2013 | CN103182017A Traditional Chinese medicine composition capable of tonifying kidney and invigorating blood circulation, and preparation method and application thereof |
| 07/03/2013 | CN103182013A Traditional Chinese medicine composition for fortifying spleen and nourishing kidney and preparation method and application thereof |
| 07/03/2013 | CN103181997A Method for processing bittersweet herb |
| 07/03/2013 | CN103181992A Nightshade processing method |
| 07/03/2013 | CN103181984A Solanum septemlobum bunge for treating prostatitis |
| 07/03/2013 | CN103181980A Processing method of dulcamara |
| 07/03/2013 | CN103181922A Application of piperidone-containing single-carbonyl curcumin compound in preparation of anti-inflammatory drug |
| 07/03/2013 | CN102526580B Chinese medicine for treating enuresis and urinary incontinence |
| 07/03/2013 | CN102441142B Medicine for treating kidney calculi |
| 07/03/2013 | CN101480419B Polysaccharide extract of Periploca forrestii Schltr, and preparation method thereof |
| 07/02/2013 | US8476280 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 07/02/2013 | US8476275 N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor |
| 07/02/2013 | US8476262 Cyanopyrroles |
| 07/02/2013 | US8476231 Conditioned cell culture medium compositions and methods of use |
| 07/02/2013 | CA2731897C Diazepine and diazocane compounds as mc4 agonists |
| 07/02/2013 | CA2445729C Use of metals to treat mucosal membranes |
| 06/27/2013 | WO2013096226A1 Trpv1 antagonists |
| 06/27/2013 | WO2013092918A1 Novel therapeutic use of p75 receptor antagonists |
| 06/27/2013 | WO2013066208A3 Pharmaceutical composition based on epigallocatechin gallate-containing nano-micelles and use thereof |
| 06/27/2013 | US20130165458 Quinazoline compounds as kinase inhibitors |
| 06/26/2013 | EP2607363A1 Fused ring compound for use as mineralocorticoid receptor antagonist |
| 06/26/2013 | EP2607358A1 Novel anti-inflammatory metabolite derived from omega-3-type fatty acid |
| 06/26/2013 | EP2607356A1 Triazole-substituted arylamide derivatives and their use as P2x3 and /or P2x2/3 purinergic receptor antagonists |
| 06/26/2013 | EP2607348A2 Plasminogen Activator Inhibitor-1 Inhibitor |
| 06/26/2013 | EP2606898A1 Composition comprising ligustroflavone, rhoifolin and hyperin, and use thereof in the preparation of a medicament |
| 06/26/2013 | EP2606894A1 Novel therapeutic use of p75 receptor antagonists |
| 06/26/2013 | EP2605763A1 Treatment |
| 06/26/2013 | CN103180314A Oxadiazole inhibitors of leukotriene production |
| 06/26/2013 | CN103173334A Hippophae rhamnoides and Fagopyrum tataricum wine and its brewage method |
| 06/26/2013 | CN103172631A Condensed pyrimidine derivative serving as transient receptor potential vanilla 3 (TRRV3) regulator |
| 06/26/2013 | CN103172619A 4-(substituted benzyl)-1(2H)-2,3-phthalazinone derivatives, and preparation methods, medicinal compositions and uses thereof |
| 06/26/2013 | CN103172562A Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein CETP |
| 06/26/2013 | CN103169916A Application of Chinese medicinal composition for preparing medicament for treating nephritis |
| 06/26/2013 | CN103169894A Traditional Chinese medicine composition for treating proteinuria |
| 06/26/2013 | CN103169816A Medicament for treating lithangiuria |
| 06/26/2013 | CN103169745A Traditional Chinese medicine composition for treating hematuria and application thereof |
| 06/26/2013 | CN103169742A Application of elaeagnus conferta roxb |
| 06/26/2013 | CN103169712A Dutasteride preparation used for increasing bioavailability and preparation method |
| 06/26/2013 | CN103169711A Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making same |
| 06/26/2013 | CN103169709A Application of thiadiazolo pyrimidone compounds in treatment of hypercalcemia and tumor bone metastases |
| 06/26/2013 | CN103169708A Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 06/26/2013 | CN103169682A Polysaccharide sulfate tablet and preparation method of polysaccharide sulfate tablet |
| 06/26/2013 | CN102671210B Clathrate compound of beta-cyclodextrin or derivatives of beta-cyclodextrin for Nifuroxazide and preparation method for preparation of clathrate compound |
| 06/26/2013 | CN102671048B Medicament for treating chronic urinary tract infections |
| 06/26/2013 | CN102196809B Agent for treatment of diabetic nephropathy |
| 06/26/2013 | CN102153630B Ring octapeptide and preparation method and application thereof in medicament making |
| 06/26/2013 | CN102088970B Improving renal function with quercetin-containing compositions |
| 06/26/2013 | CN101677975B N1,n4-bis(buta-1,3-dienyl)butane-1,4-diamine pharmaceutical compositions and methods thereof |
| 06/25/2013 | US8470852 Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators |
| 06/25/2013 | US8470783 For treating prostate cancer and malignant lymphoma; gene expression inhibition |
| 06/25/2013 | CA2633074C Elongase genes and uses thereof |
| 06/25/2013 | CA2591912C Pyrimidinylisoxazole derivatives |
| 06/25/2013 | CA2564161C Melatonin and its use in preventing postoperative complications |
| 06/25/2013 | CA2380940C Substances and agents for positively influencing collagen |
| 06/20/2013 | WO2013089212A1 Substituted triazine derivative and pharmaceutical composition containing same |
| 06/20/2013 | WO2013089164A1 Thromboembolism preventive/therapeutic agent for thromboembolism patients having severe renal dysfunction |
| 06/20/2013 | WO2013045380A3 Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
| 06/20/2013 | US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/20/2013 | DE102006044448B4 Gelartiges Basenpräparat zur Supplementierung von Spurenelementen und Verfahren zu dessen Herstellung Gel-base preparation for supplementation of trace elements and process for its production |
| 06/19/2013 | EP2604595A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 06/19/2013 | CN103160412A Health care medicinal liquor |
| 06/19/2013 | CN103159881A Preparation method for sevelamer hydrochloride |
| 06/19/2013 | CN103159880A Preparation method for sevelamer carbonate |
| 06/19/2013 | CN103159788A Condensed imidazole formamide serving as transient receptor potential vanillin 3 (TRPV3) modifier |
| 06/19/2013 | CN103159736A Substitutional pyrazol kinase inhibitor |
| 06/19/2013 | CN103159735A Substitutional imidazole kinase inhibitor |
| 06/19/2013 | CN103159726A Chromene ketone derivative used as transient receptor potential vanillin3 (TRPV3) antagonist |
| 06/19/2013 | CN103159692A Tetrazole-substituted arylamides |
| 06/19/2013 | CN103159664A Silodosin bulk drug as well as preparation method and medicine composition thereof |
| 06/19/2013 | CN103157062A Medicine composition curing gynaecological mass diseases such as fibroids and preparation method and application thereof |
| 06/19/2013 | CN103157020A Medicament for treating nephritis |
| 06/19/2013 | CN103156963A Drug for treating nephritis |
| 06/19/2013 | CN103156962A Pharmaceutical combination of pure traditional Chinese medicines used for tonifying kidney and Qi, and resolving and relieving strangury, and preparation method thereof |
| 06/19/2013 | CN103156937A Compound essential oil for relieving cystitis |
| 06/19/2013 | CN103156925A Drug for curing nephropyelitis |
| 06/19/2013 | CN103156804A Oxybutynin transdermal gel and preparation method thereof |
| 06/19/2013 | CN102861082B Application of Houttuynoid B in medicine for preventing and treating renal insufficiency |
| 06/19/2013 | CN102552784B Preparation method of traditional Chinese medicine for treating prostatitis caused by fire excess from yin deficiency |
| 06/19/2013 | CN102526623B Preparation method of traditional Chinese medicine for treating qi-blood stasis stagnant type prostatitis |
| 06/19/2013 | CN102488860B Traditional Chinese medicine composition for treating chronic uremia and preparation method thereof |
| 06/19/2013 | CN102357172B Traditional Chinese medicine composition for curing early chronic renal insufficiency |
| 06/19/2013 | CN102309542B Orthosiphon n-butanol fraction medicine for treating chronic nephritis and preparation method thereof |
| 06/19/2013 | CN101715448B Therapeutic uses of imidazol-5-carboxylic acid derivatives |
| 06/19/2013 | CN101595088B Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
| 06/13/2013 | WO2013085017A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013085016A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013084532A1 Prophylactic or therapeutic agent for dysuria |
| 06/13/2013 | WO2013084241A1 Compounds as inhibitors of renin |